Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117421) titled 'Clinical Studies on the Efficacy of IgA Nephropathy Treatment' on Jan. 23.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Beijing Hospital

Condition: Primary IgA Nephropathy

Intervention: Valid group:NA

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-08-07

Target Sample Size: Valid group:70;Invalid group:70;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=257499

Disclaimer: Curated by HT Syndication....